Pfizer Acquires a Stem-Cell Therapy
Monday, December 21, 2009 - 00:49
in Health & Medicine
Pfizer will have the rights to develop Athersys’s cells to treat inflammatory bowel disease, which is in early human testing.
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via